Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., Hawe, L. A., Leander K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745ā1749.
Davis, H. L. and Whalen, R. G. (1995) DNA-based immunization. In Molecular and Cell Biology of Human Gene Therapeutics. (Dickson, G., ed.) Chapman & Hall, New York, p. 368.
Bogen, B. (1996) Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Eur. J. Immunol. 26, 2671ā2679.
Spellerberg, M. B., Zhu, D., Thompsett, A., King, C. A., Hamblin, T. J., and Stevenson, F. K. (1997) DNA vaccines against lymphoma: Promotion of anti-idiotypic antibody responses induced by single chain Fv gene by fusion to tetanus toxin fragment C. J. Immunol. 159, 1885ā1892.
Stevenson, F. K., Zhu, D., King, C. A., Ashworth, L. J., Kumar, S., and Hawkins, R. E. (1995) Idiotypic vaccines against B-cell lymphoma. Immunol. Rev. 145, 211ā228.
George, A. J. T., and Stevenson, F. K. (1989) Prospect for the treatment of B cell tumors using idiotypic vaccination. Int. Rev. Immunol. 4, 271ā310.
George, A. J. T. Tutt, A. L., and Stevenson, F. K. (1987) Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. J. Immunol. 138, 628ā634.
Kaminski, M. S., Kitamura, K., Maloney, D. G., and Levy, R. (1987) Idiotypic vaccination against a murine B cell lymphoma: inhibition of tumor immunity by free idiotypic protein. J. Immunol. 138, 1289ā1296.
Hawkins, R. E., Zhu, D., Ovecka, M., Winter, G., Hamblin, T. J. Long, A., and Stevenson, F. K. (1994) Idiotypic vaccination against human B-cell lymphoma: rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83, 3279ā3288.
Winter, G., Griffiths, A. D., Hawkins, R. E., and Hoogenboom, H. R. (1994) Making antibodies by phage display technology. Ann. Rev. Immunol. 12, 433ā455.
Sahota, S. S., Leo, R., Hamblin, T. J., and Stevenson, F. K. (1996) IgVH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 87, 746ā755.
Levy, R., Levy, S., Cleary, M. L., Carroll, W., Kon, S., Bird, J., and Sklar, J. (1987) Somatic mutation in human B-cell tumors. Immunol. Rev. 96, 43ā58.
Panina-Bordignon, P., Tan, A., Termitjelen, A., Demotz, S., Corradin, G., and Lanzavecchia, A. (1989) Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19, 2237ā2242.
Anderson, R., Gao, X.-M., Papakonstantinopoulou, A., Roberts, M., and Dougan, cal Protocol: A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. Hum. Gene Ther. 8, 1287ā1299.
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., and Dwarki, V. (1993) Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4, 419ā431.
Pascual, V., Victor, K., Spellerberg, M., Hamblin, T. J., Stevenson, F. K., and Capra, J. D. (1992) VH restriction among human cold agglutinins. The VH-21 gene segment is required to encode anti-I and anti-i specificities. J. Immunol. 149, 2337ā2344.
Vollmers, H. P., Wozniak, E., Stepien-Bƶtsch, E., Zimmermann, U., and MĆ¼ller-Hermelink, H.-K. (1996) A rapid method for purification of monoclonal human IgM from mass culture. Hum. Antibodies Hybridomas 7, 37ā41.
Sato, Y., Roman, M. Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352ā354.
Dyke, R. J., McBride, H., George, A. J. T., Hamblin, T. J., and Stevenson, F. K. (1991) Idiotypic vaccination against B-cell lymphoma leads to dormant tumour. Cell Immunol. 132, 70ā83.
King, C. A., Spellerberg, M. B., Zhu, D., Rice, J., Sahota, S. S., Thompsett, A. R., Hamblin, T. J., Radl, J., and Stevenson, F. K. (1998) DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat. Med. 4, 1281ā1286.
Sambrook, J., Fritch, E. F., and Maniatis, T. (1989) Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Zhu, D., Spellerberg, M.B., King, C.A., Rice, J., Thompsett, A.R., Stevenson, F.K. (2000). DNA Fusion Vaccines Against B-Cell Tumors. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicineā¢, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:405
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:405
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols